EUVIMEDEUVIMED entdecken
Crossref

Successful treatment of urticarial vasculitis with omalizumab in children: a case series

Shan Wang iD, Libing Fu, Xin Xiang, Bin Zhang iD, Lin Ma, Huan Xing

Clinical and Experimental Dermatology · 2023

DOI: 10.1093/ced/llad192 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Experimental Dermatology, 2023. Verfasst von Shan Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Departments of Dermatology. Hauptthemen laut MEDLINE: Urticaria, Vasculitis, Chronic Urticaria, Anti-Allergic Agents. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 7 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Urticarial vasculitis (UV) is a small vessel leucocytoclastic vasculitis, which often needs to be distinguished from urticaria and other dermatoses. Treatment of UV in children is challenging because of the unsatisfying efficacy of antihistamines and the safety concern of long-term systemic corticosteroids or immunosuppressive agents. As a classic biological agent widely used in chronic spontaneous urticaria, omalizumab might also be a potential therapeutic option in the treatment of children with UV. This report presented four children, aged 4–6 years, with glucocorticoid-unresponsive UV successfully treated by omalizumab, thus providing evidence that omalizumab can be used to treat UV with good efficacy and tolerability in the paediatric population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

UrticariaVasculitisChronic UrticariaAnti-Allergic AgentsVasculitis, Leukocytoclastic, CutaneousChildHumansOmalizumabImmunosuppressive Agents

Substanzen

OmalizumabImmunosuppressive AgentsAnti-Allergic Agents

Autor:innen und Institutionen

  • Departments of Dermatology.
  • Pathology, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.

ORCID-Profile: Shan Wang, Bin Zhang

Zitieren

APA

Wang, S., Fu, L., Xiang, X., Zhang, B., Ma, L., & Xing, H. (2023). Successful treatment of urticarial vasculitis with omalizumab in children: a case series. Clinical and Experimental Dermatology. https://doi.org/10.1093/ced/llad192

Vancouver

Wang S, Fu L, Xiang X, Zhang B, Ma L, Xing H. Successful treatment of urticarial vasculitis with omalizumab in children: a case series. Clinical and Experimental Dermatology. 2023. doi:10.1093/ced/llad192

BibTeX
@article{Wang2023,
  author = {Wang, Shan and Fu, Libing and Xiang, Xin and Zhang, Bin and Ma, Lin and Xing, Huan},
  title = {Successful treatment of urticarial vasculitis with omalizumab in children: a case series},
  journal = {Clinical and Experimental Dermatology},
  year = {2023},
  doi = {10.1093/ced/llad192}
}
Kostenlos starten →